| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphoglycerate kinase activity | 8.01e-06 | 2 | 57 | 2 | GO:0004618 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, carboxyl group as acceptor | 2.40e-05 | 3 | 57 | 2 | GO:0016774 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 1.84e-04 | 562 | 57 | 8 | GO:0003712 | |
| GeneOntologyMolecularFunction | chromatin binding | 2.27e-04 | 739 | 57 | 9 | GO:0003682 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | NCOR1 ARID1B MAPT HGS MED14 SMARCA2 RAD54L2 ACSS2 BCL9 ARID5A GAB1 | 3.79e-04 | 1160 | 57 | 11 | GO:0030674 |
| GeneOntologyMolecularFunction | molecular adaptor activity | NCOR1 ARID1B MAPT HGS MED14 SMARCA2 RAD54L2 ACSS2 BCL9 ARID5A GAB1 | 1.38e-03 | 1356 | 57 | 11 | GO:0060090 |
| GeneOntologyMolecularFunction | transcription coactivator activity | 1.71e-03 | 303 | 57 | 5 | GO:0003713 | |
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 1.95e-03 | 23 | 57 | 2 | GO:0046965 | |
| GeneOntologyBiologicalProcess | NADH metabolic process | 5.42e-06 | 42 | 57 | 4 | GO:0006734 | |
| GeneOntologyBiologicalProcess | pancreatic D cell differentiation | 7.50e-06 | 2 | 57 | 2 | GO:0003311 | |
| GeneOntologyBiologicalProcess | NAD metabolic process | 5.50e-05 | 75 | 57 | 4 | GO:0019674 | |
| GeneOntologyBiologicalProcess | pancreas development | 1.82e-04 | 102 | 57 | 4 | GO:0031016 | |
| GeneOntologyBiologicalProcess | nicotinamide nucleotide metabolic process | 2.37e-04 | 202 | 57 | 5 | GO:0046496 | |
| GeneOntologyBiologicalProcess | pyridine nucleotide metabolic process | 2.37e-04 | 202 | 57 | 5 | GO:0019362 | |
| GeneOntologyBiologicalProcess | glycolytic process | 2.43e-04 | 110 | 57 | 4 | GO:0006096 | |
| GeneOntologyBiologicalProcess | ADP catabolic process | 2.79e-04 | 114 | 57 | 4 | GO:0046032 | |
| GeneOntologyBiologicalProcess | pyridine-containing compound metabolic process | 2.84e-04 | 210 | 57 | 5 | GO:0072524 | |
| GeneOntologyBiologicalProcess | purine nucleoside diphosphate catabolic process | 3.08e-04 | 117 | 57 | 4 | GO:0009137 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside diphosphate catabolic process | 3.08e-04 | 117 | 57 | 4 | GO:0009181 | |
| GeneOntologyBiologicalProcess | pyridine nucleotide catabolic process | 3.29e-04 | 119 | 57 | 4 | GO:0019364 | |
| GeneOntologyBiologicalProcess | central nervous system neuron differentiation | 3.30e-04 | 217 | 57 | 5 | GO:0021953 | |
| GeneOntologyBiologicalProcess | ADP metabolic process | 3.39e-04 | 120 | 57 | 4 | GO:0046031 | |
| GeneOntologyBiologicalProcess | ribonucleoside diphosphate catabolic process | 3.50e-04 | 121 | 57 | 4 | GO:0009191 | |
| GeneOntologyBiologicalProcess | pyridine-containing compound catabolic process | 3.73e-04 | 123 | 57 | 4 | GO:0072526 | |
| GeneOntologyBiologicalProcess | nucleoside diphosphate catabolic process | 3.84e-04 | 124 | 57 | 4 | GO:0009134 | |
| GeneOntologyBiologicalProcess | purine nucleoside diphosphate metabolic process | 4.87e-04 | 132 | 57 | 4 | GO:0009135 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside diphosphate metabolic process | 4.87e-04 | 132 | 57 | 4 | GO:0009179 | |
| GeneOntologyBiologicalProcess | myoblast differentiation | 5.45e-04 | 136 | 57 | 4 | GO:0045445 | |
| GeneOntologyBiologicalProcess | pyruvate metabolic process | 6.41e-04 | 142 | 57 | 4 | GO:0006090 | |
| GeneOntologyBiologicalProcess | ribonucleoside diphosphate metabolic process | 6.58e-04 | 143 | 57 | 4 | GO:0009185 | |
| GeneOntologyBiologicalProcess | pancreatic A cell differentiation | 6.68e-04 | 14 | 57 | 2 | GO:0003310 | |
| GeneOntologyCellularComponent | bBAF complex | 3.36e-04 | 10 | 58 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | npBAF complex | 6.74e-04 | 14 | 58 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | brahma complex | 6.74e-04 | 14 | 58 | 2 | GO:0035060 | |
| GeneOntologyCellularComponent | nBAF complex | 8.86e-04 | 16 | 58 | 2 | GO:0071565 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | 1.01e-03 | 934 | 58 | 9 | GO:0048471 | |
| GeneOntologyCellularComponent | tricarboxylic acid cycle heteromeric enzyme complex | 1.12e-03 | 18 | 58 | 2 | GO:0045239 | |
| Domain | PGLYCERATE_KINASE | 8.83e-06 | 2 | 56 | 2 | PS00111 | |
| Domain | Phosphoglycerate_kinase_N | 8.83e-06 | 2 | 56 | 2 | IPR015824 | |
| Domain | Phosphoglycerate_kinase_CS | 8.83e-06 | 2 | 56 | 2 | IPR015911 | |
| Domain | Phosphoglycerate_kinase_C | 8.83e-06 | 2 | 56 | 2 | IPR015901 | |
| Domain | - | 8.83e-06 | 2 | 56 | 2 | 3.40.50.1270 | |
| Domain | - | 8.83e-06 | 2 | 56 | 2 | 3.40.50.1260 | |
| Domain | PGK | 8.83e-06 | 2 | 56 | 2 | PF00162 | |
| Domain | Phosphoglycerate_kinase | 2.64e-05 | 3 | 56 | 2 | IPR001576 | |
| Domain | - | 9.04e-04 | 15 | 56 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 9.04e-04 | 15 | 56 | 2 | SM00501 | |
| Domain | ARID_dom | 9.04e-04 | 15 | 56 | 2 | IPR001606 | |
| Domain | ARID | 9.04e-04 | 15 | 56 | 2 | PS51011 | |
| Domain | ARID | 9.04e-04 | 15 | 56 | 2 | PF01388 | |
| Domain | - | 2.95e-03 | 27 | 56 | 2 | 1.10.260.40 | |
| Domain | Lambda_DNA-bd_dom | 3.40e-03 | 29 | 56 | 2 | IPR010982 | |
| Domain | SNF2_N | 4.13e-03 | 32 | 56 | 2 | IPR000330 | |
| Domain | SNF2_N | 4.13e-03 | 32 | 56 | 2 | PF00176 | |
| Domain | - | 6.24e-03 | 391 | 56 | 5 | 2.30.29.30 | |
| Domain | PH_dom-like | 8.87e-03 | 426 | 56 | 5 | IPR011993 | |
| Domain | PH | 9.62e-03 | 278 | 56 | 4 | SM00233 | |
| Domain | PH_DOMAIN | 9.74e-03 | 279 | 56 | 4 | PS50003 | |
| Domain | PH_domain | 9.86e-03 | 280 | 56 | 4 | IPR001849 | |
| Domain | - | 1.02e-02 | 283 | 56 | 4 | 1.10.10.60 | |
| Domain | PDZ | 1.05e-02 | 151 | 56 | 3 | PS50106 | |
| Domain | PDZ | 1.07e-02 | 152 | 56 | 3 | IPR001478 | |
| Pubmed | 1.64e-06 | 114 | 60 | 5 | 28245920 | ||
| Pubmed | Analysis of the cDNA and encoded protein of the human testis-specific PGK-2 gene. | 2.93e-06 | 2 | 60 | 2 | 9023984 | |
| Pubmed | Human testis-specific PGK gene lacks introns and possesses characteristics of a processed gene. | 2.93e-06 | 2 | 60 | 2 | 3453121 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 8441629 | ||
| Pubmed | Endolysosomal degradation of Tau and its role in glucocorticoid-driven hippocampal malfunction. | 2.93e-06 | 2 | 60 | 2 | 30166454 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 2298243 | ||
| Pubmed | Selective activation of testis-specific genes in cultured rat spermatogenic cells. | 2.93e-06 | 2 | 60 | 2 | 2166582 | |
| Pubmed | Human phosphoglycerate kinase. I. Crystallization and characterization of normal enzyme. | 2.93e-06 | 2 | 60 | 2 | 5009693 | |
| Pubmed | The family of mouse phosphoglycerate kinase genes and pseudogenes. | 2.93e-06 | 2 | 60 | 2 | 2829366 | |
| Pubmed | Characterization of phosphoglycerate kinase from human spermatozoa. | 2.93e-06 | 2 | 60 | 2 | 1278465 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 8662942 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 26464018 | ||
| Pubmed | Uncoupling of hypomyelination and glial cell death by a mutation in the proteolipid protein gene. | 8.77e-06 | 3 | 60 | 2 | 1380672 | |
| Pubmed | 1.15e-05 | 1049 | 60 | 10 | 27880917 | ||
| Pubmed | 1.33e-05 | 83 | 60 | 4 | 28794006 | ||
| Pubmed | 1.36e-05 | 638 | 60 | 8 | 31182584 | ||
| Pubmed | NCOR1 ARID1B ATXN2 MED14 SMARCA2 APEH PPME1 RAD54L2 BCL9 PGK1 | 1.77e-05 | 1103 | 60 | 10 | 34189442 | |
| Pubmed | 2.92e-05 | 5 | 60 | 2 | 37660994 | ||
| Pubmed | 2.92e-05 | 5 | 60 | 2 | 34769281 | ||
| Pubmed | 2.92e-05 | 5 | 60 | 2 | 12200431 | ||
| Pubmed | 2.92e-05 | 5 | 60 | 2 | 28041912 | ||
| Pubmed | 3.00e-05 | 347 | 60 | 6 | 17114649 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 3.20e-05 | 351 | 60 | 6 | 38297188 | |
| Pubmed | 3.94e-05 | 38 | 60 | 3 | 39106860 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 3.98e-05 | 220 | 60 | 5 | 35785414 | |
| Pubmed | Host-pathogen interactome mapping for HTLV-1 and -2 retroviruses. | 4.27e-05 | 39 | 60 | 3 | 22458338 | |
| Pubmed | 4.37e-05 | 6 | 60 | 2 | 22654668 | ||
| Pubmed | 4.37e-05 | 6 | 60 | 2 | 16230384 | ||
| Pubmed | Numerous BAF complex genes are mutated in Coffin-Siris syndrome. | 4.37e-05 | 6 | 60 | 2 | 25081545 | |
| Pubmed | 4.37e-05 | 6 | 60 | 2 | 8896557 | ||
| Pubmed | 4.37e-05 | 6 | 60 | 2 | 31085606 | ||
| Pubmed | 6.11e-05 | 7 | 60 | 2 | 30834655 | ||
| Pubmed | 6.11e-05 | 7 | 60 | 2 | 15448183 | ||
| Pubmed | 6.58e-05 | 45 | 60 | 3 | 19877281 | ||
| Pubmed | 7.28e-05 | 128 | 60 | 4 | 30995482 | ||
| Pubmed | 8.35e-05 | 608 | 60 | 7 | 16713569 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 9.83e-05 | 430 | 60 | 6 | 35044719 | |
| Pubmed | 1.01e-04 | 268 | 60 | 5 | 33640491 | ||
| Pubmed | 1.05e-04 | 9 | 60 | 2 | 20301446 | ||
| Pubmed | 1.05e-04 | 9 | 60 | 2 | 23669529 | ||
| Pubmed | Increased neuronal death and disturbed axonal growth in the Polμ-deficient mouse embryonic retina. | 1.31e-04 | 10 | 60 | 2 | 27172884 | |
| Pubmed | 1.31e-04 | 10 | 60 | 2 | 15922553 | ||
| Pubmed | ARID1a-DNA interactions are required for promoter occupancy by SWI/SNF. | 1.31e-04 | 10 | 60 | 2 | 23129809 | |
| Pubmed | A systematic analysis of a deep mouse epididymal sperm proteome. | 1.31e-04 | 10 | 60 | 2 | 23115268 | |
| Pubmed | SOX5 NCOR1 ARID1B ATXN2 ATAD5 HGS SMARCA2 RAD54L2 BCL9 SMAP2 | 1.54e-04 | 1429 | 60 | 10 | 35140242 | |
| Pubmed | Specification of neuronal subtypes in the spiral ganglion begins prior to birth in the mouse. | 1.59e-04 | 11 | 60 | 2 | 36409884 | |
| Pubmed | Pou2f2 Regulates the Distribution of Dorsal Interneurons in the Mouse Developing Spinal Cord. | 1.59e-04 | 11 | 60 | 2 | 31787878 | |
| Pubmed | Cloning of the genes encoding two murine and human cochlear unconventional type I myosins. | 1.59e-04 | 11 | 60 | 2 | 9119401 | |
| Pubmed | 1.64e-04 | 61 | 60 | 3 | 20305087 | ||
| Pubmed | 1.91e-04 | 486 | 60 | 6 | 20936779 | ||
| Pubmed | 1.91e-04 | 12 | 60 | 2 | 11734557 | ||
| Pubmed | 1.98e-04 | 65 | 60 | 3 | 26655900 | ||
| Pubmed | 2.07e-04 | 66 | 60 | 3 | 23275444 | ||
| Pubmed | An analysis of expression patterns of genes encoding proteins with catalytic activities. | 2.16e-04 | 67 | 60 | 3 | 17626619 | |
| Pubmed | 2.26e-04 | 13 | 60 | 2 | 17340523 | ||
| Pubmed | 2.63e-04 | 14 | 60 | 2 | 22534286 | ||
| Pubmed | Rescue of deficits by Brwd1 copy number restoration in the Ts65Dn mouse model of Down syndrome. | 2.63e-04 | 14 | 60 | 2 | 36289231 | |
| Pubmed | 2.63e-04 | 14 | 60 | 2 | 14702098 | ||
| Pubmed | DSCAM promotes axon fasciculation and growth in the developing optic pathway. | 2.63e-04 | 14 | 60 | 2 | 28137836 | |
| Pubmed | 2.63e-04 | 14 | 60 | 2 | 21804548 | ||
| Pubmed | The Midbrain Preisthmus: A Poorly Known Effect of the Isthmic Organizer. | 3.02e-04 | 75 | 60 | 3 | 37298722 | |
| Pubmed | Tlx1 and Tlx3 coordinate specification of dorsal horn pain-modulatory peptidergic neurons. | 3.03e-04 | 15 | 60 | 2 | 18400903 | |
| Pubmed | Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control. | 3.03e-04 | 15 | 60 | 2 | 17255939 | |
| Pubmed | 3.03e-04 | 15 | 60 | 2 | 23785148 | ||
| Pubmed | Developmental Requirement of Homeoprotein Otx2 for Specific Habenulo-Interpeduncular Subcircuits. | 3.03e-04 | 15 | 60 | 2 | 30593496 | |
| Pubmed | 3.03e-04 | 15 | 60 | 2 | 9891079 | ||
| Pubmed | 3.03e-04 | 15 | 60 | 2 | 11263494 | ||
| Pubmed | Mammalian SWI/SNF complexes promote MyoD-mediated muscle differentiation. | 3.03e-04 | 15 | 60 | 2 | 11175787 | |
| Pubmed | 3.03e-04 | 15 | 60 | 2 | 23523356 | ||
| Pubmed | Conditional Dicer1 depletion using Chrnb4-Cre leads to cone cell death and impaired photopic vision. | 3.03e-04 | 15 | 60 | 2 | 30783126 | |
| Pubmed | Regulation of dendritic development by neuron-specific chromatin remodeling complexes. | 3.03e-04 | 15 | 60 | 2 | 17920018 | |
| Pubmed | 3.38e-04 | 1285 | 60 | 9 | 35914814 | ||
| Pubmed | 3.39e-04 | 78 | 60 | 3 | 28611094 | ||
| Pubmed | 3.46e-04 | 16 | 60 | 2 | 28603487 | ||
| Pubmed | 3.74e-04 | 777 | 60 | 7 | 35844135 | ||
| Pubmed | Identification of a polymorphic, neuron-specific chromatin remodeling complex. | 3.91e-04 | 17 | 60 | 2 | 12368262 | |
| Pubmed | 3.91e-04 | 17 | 60 | 2 | 11078522 | ||
| Pubmed | 3.91e-04 | 17 | 60 | 2 | 19183483 | ||
| Pubmed | 3.91e-04 | 17 | 60 | 2 | 21779181 | ||
| Pubmed | Genome-scale RNAi screen for host factors required for HIV replication. | 4.01e-04 | 361 | 60 | 5 | 18976975 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 4.07e-04 | 560 | 60 | 6 | 21653829 | |
| Pubmed | ADAM10 hyperactivation acts on piccolo to deplete synaptic vesicle stores in Huntington's disease. | 4.18e-04 | 202 | 60 | 4 | 33601422 | |
| Pubmed | BAF complexes facilitate decatenation of DNA by topoisomerase IIα. | 4.40e-04 | 18 | 60 | 2 | 23698369 | |
| Pubmed | 4.40e-04 | 18 | 60 | 2 | 25794677 | ||
| Pubmed | 4.40e-04 | 18 | 60 | 2 | 20602751 | ||
| Pubmed | Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2. | 4.67e-04 | 87 | 60 | 3 | 17148452 | |
| Pubmed | 4.75e-04 | 209 | 60 | 4 | 36779422 | ||
| Pubmed | 4.91e-04 | 19 | 60 | 2 | 16932743 | ||
| Pubmed | Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes. | 4.91e-04 | 19 | 60 | 2 | 12110891 | |
| Pubmed | m6A regulation of cortical and retinal neurogenesis is mediated by the redundant m6A readers YTHDFs. | 4.91e-04 | 19 | 60 | 2 | 36039295 | |
| Pubmed | 5.15e-04 | 90 | 60 | 3 | 15033168 | ||
| Pubmed | VEGF signaling through neuropilin 1 guides commissural axon crossing at the optic chiasm. | 5.45e-04 | 20 | 60 | 2 | 21658587 | |
| Pubmed | Analysis of Presenilin 1 and 2 interacting proteins in mouse cerebral cortex during development. | 5.45e-04 | 20 | 60 | 2 | 25196998 | |
| Pubmed | 5.45e-04 | 20 | 60 | 2 | 34220450 | ||
| Pubmed | 5.45e-04 | 20 | 60 | 2 | 38267260 | ||
| Pubmed | 5.67e-04 | 93 | 60 | 3 | 27215380 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 5.99e-04 | 1105 | 60 | 8 | 35748872 | |
| Pubmed | Cul3-Klhl18 ubiquitin ligase modulates rod transducin translocation during light-dark adaptation. | 6.02e-04 | 21 | 60 | 2 | 31696965 | |
| Pubmed | Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs. | 6.02e-04 | 21 | 60 | 2 | 20195266 | |
| Pubmed | A developmental switch in the response of DRG neurons to ETS transcription factor signaling. | 6.02e-04 | 21 | 60 | 2 | 15836427 | |
| Interaction | FOXI1 interactions | 6.72e-06 | 92 | 58 | 5 | int:FOXI1 | |
| Interaction | EGR2 interactions | 9.60e-06 | 171 | 58 | 6 | int:EGR2 | |
| Interaction | TBR1 interactions | 1.83e-05 | 113 | 58 | 5 | int:TBR1 | |
| Interaction | PITX1 interactions | 3.22e-05 | 127 | 58 | 5 | int:PITX1 | |
| Interaction | ERG interactions | 4.30e-05 | 223 | 58 | 6 | int:ERG | |
| Interaction | GCM1 interactions | 4.38e-05 | 68 | 58 | 4 | int:GCM1 | |
| Interaction | TENT5B interactions | 4.64e-05 | 69 | 58 | 4 | int:TENT5B | |
| Interaction | MAPRE3 interactions | 5.10e-05 | 230 | 58 | 6 | int:MAPRE3 | |
| Interaction | NFIB interactions | 5.49e-05 | 142 | 58 | 5 | int:NFIB | |
| Interaction | FAM168A interactions | 5.49e-05 | 142 | 58 | 5 | int:FAM168A | |
| Interaction | ATXN1L interactions | 7.13e-05 | 150 | 58 | 5 | int:ATXN1L | |
| Interaction | LASP1 interactions | 7.58e-05 | 247 | 58 | 6 | int:LASP1 | |
| Interaction | PAX6 interactions | 8.34e-05 | 366 | 58 | 7 | int:PAX6 | |
| Interaction | CRX interactions | 8.84e-05 | 254 | 58 | 6 | int:CRX | |
| Interaction | NR3C1 interactions | USP6 NCOR1 ARID1B TTC28 ATAD5 MED14 SMARCA2 RAD54L2 IDH3B BCL9 ONECUT1 | 8.96e-05 | 974 | 58 | 11 | int:NR3C1 |
| Interaction | POU1F1 interactions | 9.60e-05 | 31 | 58 | 3 | int:POU1F1 | |
| Interaction | KLF4 interactions | 9.67e-05 | 160 | 58 | 5 | int:KLF4 | |
| Interaction | SOX10 interactions | 1.43e-04 | 92 | 58 | 4 | int:SOX10 | |
| Interaction | TLX1 interactions | 1.47e-04 | 175 | 58 | 5 | int:TLX1 | |
| Interaction | KRTAP26-1 interactions | 1.55e-04 | 94 | 58 | 4 | int:KRTAP26-1 | |
| Interaction | SOX17 interactions | 1.62e-04 | 95 | 58 | 4 | int:SOX17 | |
| Interaction | PPFIA2 interactions | 1.64e-04 | 37 | 58 | 3 | int:PPFIA2 | |
| Interaction | SH3TC1 interactions | 1.69e-04 | 7 | 58 | 2 | int:SH3TC1 | |
| Interaction | ALG13 interactions | 1.81e-04 | 183 | 58 | 5 | int:ALG13 | |
| Interaction | SS18L1 interactions | 1.82e-04 | 98 | 58 | 4 | int:SS18L1 | |
| Interaction | TLX3 interactions | 1.86e-04 | 291 | 58 | 6 | int:TLX3 | |
| Interaction | LHX3 interactions | 1.91e-04 | 185 | 58 | 5 | int:LHX3 | |
| Interaction | NFIA interactions | 2.06e-04 | 188 | 58 | 5 | int:NFIA | |
| Interaction | TBX2 interactions | 2.07e-04 | 40 | 58 | 3 | int:TBX2 | |
| Interaction | HNF1B interactions | 2.16e-04 | 190 | 58 | 5 | int:HNF1B | |
| Interaction | C1orf94 interactions | 2.21e-04 | 103 | 58 | 4 | int:C1orf94 | |
| Interaction | PPARG interactions | 2.48e-04 | 307 | 58 | 6 | int:PPARG | |
| Interaction | SCT interactions | 2.89e-04 | 9 | 58 | 2 | int:SCT | |
| Interaction | FEV interactions | 2.93e-04 | 203 | 58 | 5 | int:FEV | |
| Interaction | PAX8 interactions | 2.94e-04 | 111 | 58 | 4 | int:PAX8 | |
| Interaction | RFX6 interactions | 2.95e-04 | 45 | 58 | 3 | int:RFX6 | |
| Interaction | TAGLN3 interactions | 3.14e-04 | 46 | 58 | 3 | int:TAGLN3 | |
| Interaction | NFIC interactions | 3.43e-04 | 210 | 58 | 5 | int:NFIC | |
| Interaction | TBXT interactions | 3.48e-04 | 116 | 58 | 4 | int:TBXT | |
| Interaction | DTX2 interactions | 3.64e-04 | 330 | 58 | 6 | int:DTX2 | |
| Interaction | RBPMS interactions | 4.27e-04 | 340 | 58 | 6 | int:RBPMS | |
| Interaction | PAX7 interactions | 4.48e-04 | 124 | 58 | 4 | int:PAX7 | |
| Interaction | AR interactions | NCOR1 ARID1B SF3B1 KIF1A MED14 SMARCA2 RAD54L2 BCL9 PGK1 ARID5A | 4.83e-04 | 992 | 58 | 10 | int:AR |
| GeneFamily | AT-rich interaction domain containing | 4.21e-04 | 15 | 37 | 2 | 418 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | NPTX2 MAST4 NRCAM KIF1A ATXN2 MAPT PCLO ROR1 SPRYD3 C12orf76 BCL9 PGK1 MEIS2 | 1.41e-07 | 946 | 59 | 13 | M39169 |
| Coexpression | BUSSLINGER_GASTRIC_G_CELLS | 2.81e-06 | 98 | 59 | 5 | M40018 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 2.35e-07 | 196 | 59 | 6 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.50e-07 | 198 | 59 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ionocytes|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.45e-06 | 174 | 59 | 5 | 7e7b13de916cd4fa0fa6fb06e6b4942877afa9fb | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ionocytes|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.55e-06 | 175 | 59 | 5 | 13b8f7dc38c90b74d4a20a84a8705d8e2ec244f6 | |
| ToppCell | Control-B_cells|Control / group, cell type (main and fine annotations) | 3.65e-06 | 176 | 59 | 5 | 9125caa27bf790f6b1b960a86c09b4bcb1b58641 | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.75e-06 | 177 | 59 | 5 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 5.30e-06 | 190 | 59 | 5 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 5.58e-06 | 192 | 59 | 5 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.01e-06 | 195 | 59 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.01e-06 | 195 | 59 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.01e-06 | 195 | 59 | 5 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-midbrain/hindbrain_cells|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 6.32e-06 | 197 | 59 | 5 | c7078f6fcf27319ba8c5ebe700bcae7f1e7e39c1 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 6.64e-06 | 199 | 59 | 5 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.88e-05 | 159 | 59 | 4 | 7747cef94c55144fddcd024a7495318357f1351b | |
| ToppCell | COPD-Epithelial-PNEC|World / Disease state, Lineage and Cell class | 6.02e-05 | 160 | 59 | 4 | cdea93317b0ebb801ddbe73bca6149ce2c727f16 | |
| ToppCell | Control-Myeloid-Mast|Control / Disease state, Lineage and Cell class | 7.61e-05 | 170 | 59 | 4 | 9a14deb7f7cd4a49c217eba4023f7bf1dec6c902 | |
| ToppCell | Control-Myeloid-Mast|World / Disease state, Lineage and Cell class | 7.79e-05 | 171 | 59 | 4 | ed8e61d524f4cddc6084b261175df54d2a64a60f | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.79e-05 | 171 | 59 | 4 | dd37e1693a5cfc42e40992d504f92048a8038b52 | |
| ToppCell | Nasal_Brush-Epithelial-Ionocytes|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.97e-05 | 172 | 59 | 4 | dd3a23dc78dc6939f41126f8d7bd23a2e4713647 | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 7.97e-05 | 172 | 59 | 4 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | Nasal_Brush-Epithelial-Ionocytes|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.97e-05 | 172 | 59 | 4 | 04fabb40fa9357d8902f3b04adc15231626cd9f8 | |
| ToppCell | Bronchial_Brush-Epithelial-Ionocytes|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.15e-05 | 173 | 59 | 4 | e1de849dcd96063136bdac87e050ddbd55cabdcc | |
| ToppCell | Bronchial_Brush-Epithelial-Ionocytes|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.15e-05 | 173 | 59 | 4 | f2a8f4918c1fb68d98bc3f33cd624de0f0f11e06 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.15e-05 | 173 | 59 | 4 | 9a3500b06d00d1d4ee42910a3a73327b21beab52 | |
| ToppCell | Control-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 8.71e-05 | 176 | 59 | 4 | 0c5916d63e1ada09105e46d2429b75129b7329ec | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-B_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.90e-05 | 177 | 59 | 4 | b07e6139618d888a9fd7cf43cad0d86a3f63e09e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-B_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.90e-05 | 177 | 59 | 4 | 6376ec12322c04d5d37ec2fdc376700464cbc7fb | |
| ToppCell | COVID-19-B_cells-Activated_B_cells|COVID-19 / group, cell type (main and fine annotations) | 8.90e-05 | 177 | 59 | 4 | 653bb62a3744d4024ab3186ee01d410ed62832a6 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.10e-05 | 178 | 59 | 4 | ba5a477257877f4a15a91c1762ffcc6f2e9f7357 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.10e-05 | 178 | 59 | 4 | 5634c1fbc817758092af4feafff94d107412d89b | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.10e-05 | 178 | 59 | 4 | 30ca37f70d267cc9b40ca3e211f16d30360c3e6b | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.29e-05 | 179 | 59 | 4 | f2e8fc975c30992611630197b79daaeef7c4211d | |
| ToppCell | IPF-Epithelial-Mesothelial|IPF / Disease state, Lineage and Cell class | 9.50e-05 | 180 | 59 | 4 | 1fa54bf4dba72866b2295639d991af639341bc08 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.50e-05 | 180 | 59 | 4 | 7d3d5608647b6e684e8e185993d106a38c53e76a | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B-B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.70e-05 | 181 | 59 | 4 | 8d8cc4dae2c8bd5f4b1c159f2a52edc4c9449c86 | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 9.91e-05 | 182 | 59 | 4 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | COPD-Myeloid-Mast|World / Disease state, Lineage and Cell class | 9.91e-05 | 182 | 59 | 4 | 68a1e7b804f309bfd6c23d65fad20a9a962712ae | |
| ToppCell | IPF-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 1.01e-04 | 183 | 59 | 4 | 7df20e3172a1220ff427f30181f4f0c3b7fe2d42 | |
| ToppCell | IPF-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 1.03e-04 | 184 | 59 | 4 | 7326a16d7d3ae41b8c9d2beaec7f977b374f3469 | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.03e-04 | 184 | 59 | 4 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | COPD-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 1.06e-04 | 185 | 59 | 4 | 23579988036fc1925992c31919750f9b3fe9f790 | |
| ToppCell | COPD-Myeloid-Mast|COPD / Disease state, Lineage and Cell class | 1.08e-04 | 186 | 59 | 4 | def6f0f284acc2154738574c8c5d3d2a5ef1f208 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.08e-04 | 186 | 59 | 4 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.10e-04 | 187 | 59 | 4 | fa01a61bfd13feb033ba1e35cf513707b1bff8c8 | |
| ToppCell | 10x5'-Lung-Mast|Lung / Manually curated celltypes from each tissue | 1.10e-04 | 187 | 59 | 4 | f8ac5ca5cbe9c6f3d8c0fffc20fe08ca1aea43c0 | |
| ToppCell | 10x5'-Lung-Mast-Mast_cells|Lung / Manually curated celltypes from each tissue | 1.10e-04 | 187 | 59 | 4 | da275d2c774b3e6a8ed77f777dd0676ecf2ddd2c | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 1.12e-04 | 188 | 59 | 4 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 188 | 59 | 4 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.12e-04 | 188 | 59 | 4 | d8decd9b5967873ca8320c2f9f07365f163c777f | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 1.12e-04 | 188 | 59 | 4 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 188 | 59 | 4 | 1f07e3ab87173426fe0c429f5c084fb3425effd3 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 188 | 59 | 4 | 85746f95319e494efdc1bbc24331698688d3a900 | |
| ToppCell | COPD-Epithelial-Mesothelial|COPD / Disease state, Lineage and Cell class | 1.15e-04 | 189 | 59 | 4 | 79bb2593ad5d17f94b17972884241f03a0f43770 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 189 | 59 | 4 | 6463890d8dbee4bc198f91628a5f784970de786a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.17e-04 | 190 | 59 | 4 | 0724665ac8238f2383c3a929d89abf4a48ec2420 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.17e-04 | 190 | 59 | 4 | 5f1863bce9400b7c932f0e4d0e012ec4e8d7e555 | |
| ToppCell | COPD-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 1.17e-04 | 190 | 59 | 4 | 379dbac19110b76079a7a53209569e060a852acb | |
| ToppCell | COPD-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 1.19e-04 | 191 | 59 | 4 | ef16ad1c1cd2c0c0377957398c98775b62a81754 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.19e-04 | 191 | 59 | 4 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 1.19e-04 | 191 | 59 | 4 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | facs-Pancreas|facs / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 191 | 59 | 4 | d48e5f67d384226add7d7fb2a124954136e09a82 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 191 | 59 | 4 | 3387b95a3f2445c672d407922fdce3a91eabaef8 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 1.22e-04 | 192 | 59 | 4 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.22e-04 | 192 | 59 | 4 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-Naive_B_cells|bone_marrow / Manually curated celltypes from each tissue | 1.22e-04 | 192 | 59 | 4 | fa99243ff028498c6a67d207a93e02c48e69cd42 | |
| ToppCell | IPF-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 1.22e-04 | 192 | 59 | 4 | e911e286da26202853f9650ba3cdefe5a5c9b585 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 192 | 59 | 4 | 1304e69c92cef3bd8c82e3c035a7562f5440139a | |
| ToppCell | Control-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 1.22e-04 | 192 | 59 | 4 | 7e89b9125e8b85f6be85eeccef5c8644647ab0e1 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-04 | 192 | 59 | 4 | 56b021c297a21dff357531f21e2464f85186106d | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.24e-04 | 193 | 59 | 4 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-B_cells-Naive_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.24e-04 | 193 | 59 | 4 | 8d88f3b0d08f9dbae26ee122dbd43f06e2cc3f67 | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 194 | 59 | 4 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 194 | 59 | 4 | 5c3b2b05d1e4f146551fe4c920263d8e6ca34de3 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.27e-04 | 194 | 59 | 4 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 194 | 59 | 4 | ab9cad697f9209d2889bc02b43b502dfeb2ebfef | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.27e-04 | 194 | 59 | 4 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.29e-04 | 195 | 59 | 4 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-04 | 195 | 59 | 4 | 6bdef651cf73d7381e5012d0eb3c809138fb6b92 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_cell-B_mature|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.29e-04 | 195 | 59 | 4 | 3311a1bf4ed94820b45047d44fc14b14ac72e6fb | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.29e-04 | 195 | 59 | 4 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 195 | 59 | 4 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-midbrain/hindbrain_cells|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.32e-04 | 196 | 59 | 4 | 0767581b69bc7e6334d580ca02ed1e831b7b55da | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.32e-04 | 196 | 59 | 4 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-04 | 196 | 59 | 4 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.32e-04 | 196 | 59 | 4 | 4bdc304c0c9d8bebe1a6a8a27e44acd1e8113725 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-04 | 197 | 59 | 4 | da61afba697ec49ca86e062d35a825280da558ac | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-04 | 197 | 59 | 4 | ad4a3b5da2190be9495382a2952991e1de9f190d | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 1.34e-04 | 197 | 59 | 4 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-04 | 197 | 59 | 4 | 0f489d26e4013d1b5a90559856ed2de32a0bb772 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | 1.34e-04 | 197 | 59 | 4 | d20f29088e9afd8a960d6f680075c380e550f8a7 | |
| ToppCell | PCW_10-12|World / Celltypes from embryonic and fetal-stage human lung | 1.34e-04 | 197 | 59 | 4 | 47fd8b0d596c5db1a722473c8efbb17a6bbe7538 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_cell-B_mature|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-04 | 198 | 59 | 4 | 863765ccc0205dc28864dae85af339c283194c96 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-B-B_cell-B_mature|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-04 | 198 | 59 | 4 | 4aa4ae2571effcfb6eb6923f7173cd3e7e4af9ef | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-04 | 198 | 59 | 4 | 8f25e8dff42bad8e779ca618bdb1cb1610667962 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-04 | 198 | 59 | 4 | e3e0aa3ef20b2370f5b133048510677aaa562dfa | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.37e-04 | 198 | 59 | 4 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-04 | 199 | 59 | 4 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-04 | 199 | 59 | 4 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Transverse-(1)_T_cell-(16)_Tfh|Transverse / shred on region, Cell_type, and subtype | 1.40e-04 | 199 | 59 | 4 | aa31e26d48066f865ca33251a33a28934c0a7a44 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-04 | 199 | 59 | 4 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| Drug | Ms B | 2.52e-06 | 37 | 59 | 4 | CID003952261 | |
| Drug | 4-Arsono-2-hydroxybutanoic acid | 6.60e-06 | 2 | 59 | 2 | CID000135804 | |
| Drug | Dihydroergotamine tartrate [5989-77-5]; Down 200; 3uM; PC3; HT_HG-U133A | 1.13e-05 | 195 | 59 | 6 | 4502_DN | |
| Drug | (-)-Isoproterenol hydrochloride [5984-95-2]; Down 200; 16.2uM; PC3; HT_HG-U133A | 1.13e-05 | 195 | 59 | 6 | 4495_DN | |
| Drug | Mianserine hydrochloride [21535-47-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 1.23e-05 | 198 | 59 | 6 | 5786_DN | |
| Drug | juglone | 1.55e-05 | 58 | 59 | 4 | CID000003806 | |
| Drug | Dirian | 1.98e-05 | 3 | 59 | 2 | CID003034337 | |
| Drug | AC1NDNJY | 1.98e-05 | 3 | 59 | 2 | CID004578722 | |
| Drug | AC1O5U9L | 1.98e-05 | 3 | 59 | 2 | CID006440811 | |
| Drug | citric acid | 3.72e-05 | 357 | 59 | 7 | CID000000311 | |
| Drug | repin | 3.95e-05 | 4 | 59 | 2 | CID000091567 | |
| Drug | clorsulon | 6.57e-05 | 5 | 59 | 2 | CID000043231 | |
| Drug | glyoxylate | 9.31e-05 | 176 | 59 | 5 | CID000000760 | |
| Drug | CDVpp | 9.84e-05 | 6 | 59 | 2 | CID000501655 | |
| Drug | esperamicin A1 | 9.84e-05 | 6 | 59 | 2 | CID006435576 | |
| Drug | pyruvic acid | 1.09e-04 | 424 | 59 | 7 | CID000001060 | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.12e-04 | 183 | 59 | 5 | 5613_DN | |
| Drug | AC1L9GHY | 1.31e-04 | 38 | 59 | 3 | CID000444538 | |
| Drug | Estriol [50-27-1]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 1.37e-04 | 191 | 59 | 5 | 7220_DN | |
| Drug | SC-11927 | 1.37e-04 | 7 | 59 | 2 | CID003034422 | |
| Drug | ethyl octanoate | 1.37e-04 | 7 | 59 | 2 | CID000007799 | |
| Drug | Bambuterol hydrochloride [81732-46-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.51e-04 | 195 | 59 | 5 | 7239_DN | |
| Drug | Tiaprofenic acid [33005-95-7]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 1.51e-04 | 195 | 59 | 5 | 2852_DN | |
| Drug | Apramycin [37321-09-8]; Down 200; 7.4uM; PC3; HT_HG-U133A | 1.51e-04 | 195 | 59 | 5 | 6614_DN | |
| Drug | Isoconazole [27523-40-6]; Down 200; 9.6uM; PC3; HT_HG-U133A | 1.54e-04 | 196 | 59 | 5 | 2056_DN | |
| Drug | Cefaclor [70356-03-5]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 1.54e-04 | 196 | 59 | 5 | 2843_UP | |
| Drug | pioglitazone HCl; Down 200; 10uM; MCF7; HT_HG-U133A | 1.58e-04 | 197 | 59 | 5 | 7523_DN | |
| Drug | LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A | 1.58e-04 | 197 | 59 | 5 | 5236_DN | |
| Drug | Deltaline [6836-11-9]; Down 200; 7.8uM; PC3; HT_HG-U133A | 1.58e-04 | 197 | 59 | 5 | 3750_DN | |
| Drug | PNU-0230031 [267429-39-0]; Down 200; 1uM; MCF7; HT_HG-U133A | 1.62e-04 | 198 | 59 | 5 | 3632_DN | |
| Drug | Amodiaquin dihydrochloride dihydrate [6398-98-7]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 1.62e-04 | 198 | 59 | 5 | 6224_DN | |
| Drug | Dihydroergocristine mesylate [24730-10-7]; Down 200; 5.6uM; MCF7; HT_HG-U133A | 1.62e-04 | 198 | 59 | 5 | 2895_DN | |
| Drug | Chlorthalidone [77-36-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.62e-04 | 198 | 59 | 5 | 3198_DN | |
| Drug | oxaloacetate | 1.62e-04 | 198 | 59 | 5 | CID000000970 | |
| Drug | Nitrofurantoin [67-20-9]; Up 200; 16.8uM; MCF7; HT_HG-U133A | 1.66e-04 | 199 | 59 | 5 | 2303_UP | |
| Drug | Leucomisine [17946-87-1]; Up 200; 16.2uM; PC3; HT_HG-U133A | 1.66e-04 | 199 | 59 | 5 | 7125_UP | |
| Drug | Procainamide hydrochloride [614-39-1]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 1.66e-04 | 199 | 59 | 5 | 2618_DN | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; PC3; HT_HG-U133A | 1.69e-04 | 200 | 59 | 5 | 3714_UP | |
| Drug | ethyl decanoate | 1.83e-04 | 8 | 59 | 2 | CID000008048 | |
| Drug | phenethyl acetate | 2.35e-04 | 9 | 59 | 2 | CID000007654 | |
| Drug | AC1MI08J | 2.35e-04 | 9 | 59 | 2 | CID003035924 | |
| Drug | Rh(H2O)4ATP | 2.35e-04 | 9 | 59 | 2 | CID003082848 | |
| Drug | chloroethylguanine | 2.35e-04 | 9 | 59 | 2 | CID000161383 | |
| Drug | 2-methoxy-5-nitrotropone | 2.35e-04 | 9 | 59 | 2 | CID000084563 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 3.78e-05 | 5 | 58 | 2 | C3281201 | |
| Disease | cortical surface area measurement | SOX5 ILDR2 NCOR1 ARID1B SF3B1 MAST4 ATXN2 MAPT ROR1 MEIS2 ITIH5 | 5.36e-05 | 1345 | 58 | 11 | EFO_0010736 |
| Disease | interleukin-23 measurement | 5.67e-05 | 6 | 58 | 2 | EFO_0020501 | |
| Disease | orofacial cleft (is_implicated_in) | 7.92e-05 | 7 | 58 | 2 | DOID:0050567 (is_implicated_in) | |
| Disease | forced expiratory volume | 1.48e-04 | 789 | 58 | 8 | EFO_0004314 | |
| Disease | Parkinson disease, late-onset | 1.69e-04 | 10 | 58 | 2 | cv:C3160718 | |
| Disease | PARKINSON DISEASE, LATE-ONSET | 1.69e-04 | 10 | 58 | 2 | 168600 | |
| Disease | late onset Parkinson's disease (is_implicated_in) | 2.06e-04 | 11 | 58 | 2 | DOID:0060892 (is_implicated_in) | |
| Disease | neuroimaging measurement | 2.24e-04 | 1069 | 58 | 9 | EFO_0004346 | |
| Disease | PARKINSON DISEASE, LATE-ONSET | 2.47e-04 | 12 | 58 | 2 | C3160718 | |
| Disease | Coffin-Siris syndrome | 2.92e-04 | 13 | 58 | 2 | C0265338 | |
| Disease | response to 5-fluorouracil, response to cyclophosphamide, chemotherapy-induced alopecia, response to doxorubicin | 3.40e-04 | 14 | 58 | 2 | EFO_0005400, GO_0036275, GO_1902518, GO_1902520 | |
| Disease | juvenile idiopathic arthritis | 4.23e-04 | 74 | 58 | 3 | EFO_0002609 | |
| Disease | facial asymmetry measurement | 6.36e-04 | 19 | 58 | 2 | EFO_0009751 | |
| Disease | vital capacity | 6.46e-04 | 1236 | 58 | 9 | EFO_0004312 | |
| Disease | acetate measurement | 7.05e-04 | 20 | 58 | 2 | EFO_0010112 | |
| Disease | Autoimmune Hepatitis | 7.78e-04 | 21 | 58 | 2 | EFO_0005676 | |
| Disease | breast cancer, COVID-19 | 8.55e-04 | 22 | 58 | 2 | MONDO_0007254, MONDO_0100096 | |
| Disease | Parkinson disease | 8.55e-04 | 22 | 58 | 2 | cv:C0030567 | |
| Disease | biological sex | 1.10e-03 | 230 | 58 | 4 | PATO_0000047 | |
| Disease | glycerol measurement | 1.20e-03 | 26 | 58 | 2 | EFO_0010115 | |
| Disease | type 1 diabetes mellitus | 1.32e-03 | 242 | 58 | 4 | MONDO_0005147 | |
| Disease | cortical thickness | 1.44e-03 | 1113 | 58 | 8 | EFO_0004840 | |
| Disease | cancer (implicated_via_orthology) | 1.92e-03 | 268 | 58 | 4 | DOID:162 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IASSMPPSPMGHYQG | 386 | Q9NVA4 | |
| MVGVLAMAAAAAPPP | 1 | Q96QE3 | |
| TAGPSPMAAGLMHFP | 541 | Q03989 | |
| HGIPPQMMGGPLQSS | 1511 | Q8NFD5 | |
| IPMMPRHVPLGGSVS | 1031 | Q9Y4B4 | |
| GGHMLTPLPGATPMK | 471 | Q9NR19 | |
| PDIVTMGKPMGNGHP | 271 | Q8TBG4 | |
| MSHLGRPDGVPMPDK | 61 | P07205 | |
| IAGHLMTPPISPAMA | 636 | Q8HWS3 | |
| LPPPIMLIGHSMGGA | 146 | Q9Y570 | |
| LPVAAVQPMTGGMAP | 721 | O95170 | |
| HPDTRGMCKGMPSPE | 51 | Q8N7Z5 | |
| HPAAAAAMNMPSGLP | 201 | Q01851 | |
| AAMNMPSGLPHPGLV | 206 | Q01851 | |
| LSPMGVPRAGHVMAA | 401 | A6NCF5 | |
| GVLMVHPSAPGAPMA | 126 | Q9UJ55 | |
| GVLMVQPAAPGAPMV | 246 | Q9UJ55 | |
| APMAKPPGPGVLMIH | 276 | Q9UJ55 | |
| AHGMSAAMGPEPVVQ | 636 | Q86UX2 | |
| VMGHSGEDLPMVAPG | 836 | Q92823 | |
| PGPMVVFATPGMLHA | 316 | Q5TA45 | |
| MVIPAGPSMGAPKHT | 1796 | Q86WG5 | |
| GMQVPPPAHMGFRSS | 486 | Q13480 | |
| PHPNVMPASMGSAVN | 56 | O14770 | |
| MMHPASAAGPPIAAT | 1016 | Q99700 | |
| MMAPPTHAQPGLVSS | 1076 | Q99700 | |
| MGMARAAAGPLPPIS | 4371 | Q9Y6V0 | |
| RGSHLPPAHPRSMGM | 41 | Q9UBC0 | |
| AHPGAAMPTDKMLTP | 201 | Q9UBC0 | |
| MSHLGRPDGVPMPDK | 61 | P00558 | |
| PGLPPAHSGTLMMAF | 471 | Q9UPP2 | |
| AARMPGMSPANPSLH | 1121 | O60244 | |
| VLLLPHGMEGMGPEH | 776 | Q02218 | |
| VTMLPGDGVGPELMH | 51 | O43837 | |
| PPPVIVNGKHTGMMA | 721 | P20023 | |
| GVPMGPGLMSHNPIM | 1106 | O00512 | |
| PPTMGMGHVRVPAAH | 836 | O75128 | |
| PTVIIANMMHGGPAE | 681 | Q02410 | |
| IPGDMFAVSPLGSPM | 1096 | O15021 | |
| PSPVTSPVHMMGTGI | 436 | Q9P267 | |
| MPVPGPNGTILMETH | 106 | O15431 | |
| IPPPRGNGVTMGMVA | 136 | A1KXE4 | |
| IPAVVDHRGGMPCMG | 1151 | Q12756 | |
| HSMMGPSPGPPSVSH | 41 | P51531 | |
| DHGVVMSQPMGVVPG | 2281 | O75376 | |
| MPHLPGDVLHSPGDM | 316 | Q8NDZ2 | |
| AVHAGCPLPAMPMQG | 36 | P47972 | |
| DKTQVPMVVMPHGGP | 496 | P13798 | |
| PMVVMPHGGPHSSFV | 501 | P13798 | |
| GAVAMAPEMLPKHPH | 276 | Q96LP6 | |
| SNHAGMGPILPAMPS | 86 | Q8N812 | |
| MGPILPAMPSVDGNH | 91 | Q8N812 | |
| PHMSIPNHPGGMGIT | 886 | Q01973 | |
| RMPPRKDSIHAGGPM | 476 | P48454 | |
| PMSPDGLFPAVGMHS | 176 | Q8NCJ5 | |
| PPVGMVAQPGASGMV | 316 | Q8WU79 | |
| KPGHINMAAAGIPAM | 236 | A6NJ88 | |
| GAPSSGMLMDKPHPP | 266 | Q71H61 | |
| GTPAMNMATPTPGHI | 361 | O75533 | |
| GSPMHGVYMSQPAPA | 601 | O14964 | |
| SHQLMSGMPGAPLLP | 146 | P10636 | |
| IAPMEGGLMHSSGPV | 1401 | Q96AY4 | |
| VYPGAIAMAGMPSPH | 676 | P35711 | |
| IAMAGMPSPHLPSEH | 681 | P35711 | |
| MMQFTAPIPGATGPI | 136 | Q5SRN2 | |
| IHVPPLDPSMGMGHL | 971 | Q702N8 | |
| GMVNGHMPSLPDSPF | 856 | P35125 | |
| MMGTGLPPYPEHLTS | 221 | Q6ZMS7 |